Innovative Multidisciplinary Strategies for Combating Severe Dengue

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKarolinska Institutet

About this trial

The goal of this observational study is to identify biomarkers and host factors associated with dengue severity in patients from dengue-endemic regions. The main question it aims to answer is:

Can multi-omics approaches predict disease severity and identify key factors contributing to severe dengue infections?

Participants will include individuals with dengue infection, and the study will analyze their blood samples using multi-omics techniques to uncover host immune responses, disease pathogenesis, and cellular pathway interactions. The study will also assess the role of primary and secondary infections, virus serotypes, and immunological factors in disease progression. Findings aim to support disease management, improve severity prediction, and identify potential therapeutic targets to prevent severe outcomes.

Eligibility criteria

Qualifiers

Myalgia, arthralgia

Nausea and/or vomiting

Rashes

Leukopenia Group 2: DENV with warning signs This cohort will include patients with the above symptoms and any of the following clinical signs.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Infection and no infection

Treatment groups

1,400 Participants
are divided into 4 treatment groups

Sponsors and collaborators

Karolinska Institutet

Lead sponsor

BIO BOX GUATEMALA ONG DE INVESTIGACIÓN, SERVICIOS Y DE MEDIO AMBIENTE

Collaborator

DEVKI DEVI FOUNDATION SOCIETY, India

Collaborator

MANIPAL ACADEMY OF HIGHER EDUCATION, India

Collaborator

Artemis Medicare Services Ltd., India

Collaborator